Quote:

---

I heard up to $300B for Lympro

---

I think you might have heard wrong. That number is way out of line. Perhaps you meant the annual amount spent on Alzheimer's treatments.

How is LymPro going to generate $300 Billion in any capacity, either as a diagnostic or the sale price of the asset to big pharma? This number doesn't make sense for what we know about LymPro and the target market as a diagnostic test. I'm not sure in what context your figure applies to LymPro.